R&D Day
Evaxion to host R&D day on May 25th, 2023
The R&D Day will feature a series of talks from Evaxion scientists and collaborators, sharing previously unreleased preclinical data highlighting the use of Evaxion’s proprietary genetic immune adjuvant (Antigen Presenting Cell targeting) technology. This technology has been shown to enhance vaccination effects for both DNA and mRNA vaccines across a range of therapeutic vaccine applications.
The event will be hosted with the possibility for physical attendance at Evaxion’s facilities in Hørsholm, Denmark and as a live webcast.
Please write to info@evaxion-biotech.com with the following details to sign up for the physical attendance for R&D day:
Subject: R&D Day
Message: Your full name
Dr Neergaards Vej 5F,
2970 Hørsholm
Denmark
Agenda
- 12.30-12.45 Welcome to Evaxion R&D day and program of the day
- 12.45-13.00 Introduction to Evaxion's DNA vaccine technology & Antigen Presenting Cell targeting (APCt)
- 13.00-13.15 APCt and cancer neoepitopes vaccines
- 13.15-13.30 APCt and tumor specific ERV vaccines
- 13.30-13.40 Q&A session
- 13.40-14.00 BREAK
- 14.00-14.20 Pantherna’s mRNA-LNP technologies
- 14.20-14.35 APCt and mRNA-LNP delivery of cancer neoepitopes
- 14.35-14.45 Q&A session
- 14.45-15.00 SHORT BREAK
- 15.00-15.10 APCt and viral vaccines
- 15.10-15.20 APCt and bacterial vaccines
- 15.20-15.30 Q&A session
- 15.20-15.30 THANK YOU and concluding remarks
- 15.30-17.00 Reception with drinks and snacks